John Amos, Dr. Farhad Zangeneh, Medical Director of Endocrine, Diabetes and Osteoporosis Clinic, Dr. Dina Peralta-Reich, New York Weight Wellness Medicine Founder and Director, and Peter Maher, a ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...